Vol. 35 (3) 2014 Neuro endocrinology letters

Anti-inflammatory effects of bromocriptine in a patient with autoimmune polyglandular syndrome type 2.

: Excessive prolactin release and/or receptor action may be implicated in the pathogenesis of many autoimmune disorders. We report here a case of a woman who developed Graves' disease and subclinical autoimmune adrenal failure, and was diagnosed as having autoimmune polyglandular syndrome type 2. Because of coexisting microprolactinoma .....